Dietmar Berger
Chief Medical Officer at Gilead Sciences
Gilead Sciences•Foster City, California, United States
View LinkedIn ProfileExperience38+ Years
LevelCXO
Executive Overview
Experienced in preclinical and clinical drug development, with demonstrated accomplishments in the biotechnology and pharmaceutical industry, preclinical research, clinical development study phases 1 through 4, global filings, regulatory approvals, medical affairs. Board-certified Internist, Hematologist and Oncologist with full academic credentials and clinical experience. Strategic mindset with excellent leadership and communication skills.
Career Timeline
- Gilead SciencesCurrent2025–Present· 1 yr 8 mos
- Chief Medical OfficerCurrent2025–Present
- May 2019–Dec 2024· 5 yrs 7 mos
- Chief Medical Officer, Global Head of DevelopmentFeb 2020–Dec 2024
- Senior Vice President, Global Head of DevelopmentMay 2019–Feb 2020
- May 2018–May 2019· 1 yr
- Director, Global Research and DevelopmentMay 2018–May 2019
- Dec 2011–May 2018· 6 yrs 5 mos
- Senior Vice President, Global Clinical Development, Hematology/OncologyMar 2014–May 2018
- Vice President, Global Clinical Development, Hematology/OncologyDec 2011–Mar 2014
- Oct 2009–Nov 2011· 2 yrs 1 mo
- Vice President, Global Clinical Development, Therapeutic Area Head, OncologyOct 2009–Nov 2011
- 1999–Oct 2009· 10 yrs 9 mos
- Group Leader, Executive Director, Global Clinical Development, Hematology/Oncology2005–Oct 2009
- Therapeutic Area Head, Hematology/Oncology2003–2005
- Head Medical Department1999–2003
- 1997–1999· 2 yrs
- Research Physician1997–1999
- 1988–1997· 9 yrs
- Attending and Professor1988–1997
Education
MD PhD
Human Medicine
The University of FreiburgExecutive Relationship Map
Reports To
Dietmar Berger
Vice Chair & President
Chief Financial Officer
Chief Technology Officer
Chief Operating Officer
Skills & Expertise
CommercializationMedical AffairsHealth EconomicsPharmacologyOncologyClinical ResearchBiopharmaceuticalsHematologyImmunologyMedicineFDADrug DevelopmentGCPClinical DevelopmentClinical TrialsTherapeutic AreasPharmaceutical IndustryLifesciencesBiotechnologyCancer